Today: 10 April 2026
Tesla’s Stock Skyrockets on AI Hype – Latest Price Jump, Earnings Shocks & Bold 2025 Forecasts

Tesla Stock Today (Nov 7, 2025): TSLA slips as shareholders OK Musk’s $1T pay; new FSD China timeline, Cybercab for 2026, and chip-fab hints

Published: November 7, 2025


Key takeaways

  • TSLA is trading lower today after shareholders approved Elon Musk’s record pay plan; intraday range shows elevated volatility.
  • Shareholders gave advisory approval for a potential Tesla investment in Musk’s AI startup xAI, while a proposal to eliminate certain supermajority voting rules did not pass.
  • Musk guided that Full Self‑Driving (FSD) could win full regulatory approval in China in early 2026.
  • Tesla aims to start “Cybercab” production in April 2026; Roadster reveal is targeted for April 1, 2026. TechCrunch+1
  • Musk says Tesla may need a “gigantic” AI chip fab and is exploring an Intel tie‑up, alongside existing supplier work with TSMC and Samsung. Reuters+1

TSLA price action (as of 18:47 UTC)

  • Price: $430.74 (‑3.4% on the day)
  • Open / High / Low: $437.60 / $456.30 / $422.09
  • Context: The broader U.S. market is softer (SPY −0.7% intraday).
    Prices are real‑time snapshots and may change.

What moved the stock today

1) Shareholders approved Musk’s record pay plan
At yesterday’s annual meeting in Austin, investors voted in favor of a performance‑based compensation package for CEO Elon Musk that could be worth up to $1 trillion if aggressive operational and valuation milestones are met. Coverage indicates support exceeded 75% of votes cast.

2) Governance results beyond the headline
Preliminary tallies show an advisory (non‑binding) “yes” to authorizing a Tesla investment in xAI, with many abstentions; the board will determine next steps. Separately, proposals to replace certain supermajority voting requirements with simple‑majority rules did not pass. Business Insider’s running recap also noted board declassification (all directors elected annually) as approved. Business Insider

3) Market reaction
Morning coverage flagged a 4–5% drop in TSLA after the vote, reflecting mixed buy‑side sentiment toward governance and execution risk. By early afternoon, shares remained lower but off session lows.


Product, autonomy, and AI roadmap updates from the meeting

FSD in China: early‑2026 target
Musk said Tesla expects full regulatory approval for FSD in China around February–March 2026. China remains strategically important as local rivals scale advanced driver‑assist features.

Cybercab production timing
Tesla plans to begin Cybercab (steering‑wheel‑less robotaxi) production in April 2026 at the Texas gigafactory. Musk pitched a radically fast assembly cadence, framing the build more like consumer electronics than traditional auto lines.

Roadster reveal date
The long‑anticipated second‑gen Roadster is slated for an April 1, 2026 reveal, with Musk hinting at major design and tech changes versus the 2017 prototype.

Chips: from suppliers to a possible Tesla “terafab”
Musk said Tesla may need to build a “gigantic” in‑house AI chip facility to meet compute demand for autonomy and robotics, while exploring a potential collaboration with Intel and continuing to work with TSMC and Samsung. Any fab decision would be capital‑intensive and multi‑year in nature. Reuters+1


How investors are framing today’s move

Governance vs. execution. The pay vote reduces uncertainty around Musk’s ongoing involvement but concentrates attention on execution of audacious targets (robotaxis, humanoid robots, FSD at scale, multi‑trillion valuation milestones). That trade‑off is front and center in analyst and investor commentary today.

Policy and stakeholder pushback. Public officials and some institutions criticized the award, arguing it grants disproportionate power and misaligns incentives. That narrative may persist as Tesla pursues autonomy and AI at scale.

Macro backdrop. Broader U.S. equities are modestly lower intraday, a headwind for high‑beta names like TSLA.


What to watch next

  • Formal board communication on xAI investment (scope, structure, and governance safeguards).
  • Regulatory milestones in China for FSD and any pilot expansions before full approval.
  • Robotaxi program details (capex, fleet deployment model, regulatory pathways) as April 2026 approaches.
  • Semiconductor strategy—clarity on supplier mix, any Intel partnership, and whether Tesla will pursue its own fab.

Bottom line

TSLA is lower today as the market digests a historic CEO pay approval alongside ambitious autonomy and AI promises. The near‑term focus will be on execution milestones (FSD progress in China, Cybercab industrialization) and governance follow‑through (xAI and voting‑rule outcomes). For now, price action reflects both the size of the bet on Musk—and the burden of proof ahead.


Disclosure: This article is for informational purposes only and is not investment advice.

Stock Market Today

  • Morgan Stanley Raises Price Target for Regeneron Pharmaceuticals STOCK
    April 10, 2026, 12:29 PM EDT. Morgan Stanley increased its price target for Regeneron Pharmaceuticals (NASDAQ:REGN) from $769 to $796, indicating a potential 6.36% upside. The biopharmaceutical stock is rated "equal weight" by Morgan Stanley. Other analysts show mixed views: Piper Sandler rates it "overweight" with an $875 target, while Guggenheim and JPMorgan raised their targets to $975 and $950 respectively, maintaining buy ratings. Regeneron's average analyst rating is "Moderate Buy" with a target near $812. The stock dropped 2.5% to $748.42 on Friday, below the 50-day average of $767.27. The company reported strong Q4 earnings with EPS of $11.44, beating estimates, and revenue grew 2.5% year-over-year to $3.88 billion. Market cap stands at $79.12 billion with a P/E ratio of 17.99.

Latest article

UK Stock Market Today: FTSE 100 Climbs as Traders Eye Fragile Iran Ceasefire

UK Stock Market Today: FTSE 100 Climbs as Traders Eye Fragile Iran Ceasefire

10 April 2026
London’s FTSE 100 rose 0.38% to 10,644.28 late Friday morning as investors awaited U.S.-Iran talks in Pakistan. Brent crude climbed 1% to $96.83 a barrel, while sterling eased but was on track for its biggest weekly gain since January. The FTSE 250 gained 0.79%. Britain’s 10-year gilt yield stood at 4.807%.
US Stock Market Today: CPI, Oil and Iran Truce Set the Tone Before the Open

US Stock Market Today: CPI, Oil and Iran Truce Set the Tone Before the Open

10 April 2026
Dow e-minis slipped 0.15% before Friday’s open, with S&P 500 and Nasdaq 100 futures each down 0.08% as traders awaited March CPI data and watched U.S.-Iran tensions. Economists expect headline CPI to rise 0.9% for March and 3.3% year-on-year. Weekly jobless claims increased to 219,000. Brent crude traded near $97 a barrel, while shipping through the Strait of Hormuz remained well below normal.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 10.04.2026

10 April 2026
LIVEMarkets rolling coverageStarted: April 10, 2026, 12:00 AM EDTUpdated: April 10, 2026, 12:29 PM EDT Morgan Stanley Raises Price Target for Regeneron Pharmaceuticals STOCK April 10, 2026, 12:29 PM EDT. Morgan Stanley increased its price target for Regeneron Pharmaceuticals (NASDAQ:REGN) from $769 to $796, indicating a potential 6.36% upside. The biopharmaceutical stock is rated "equal weight" by Morgan Stanley. Other analysts show mixed views: Piper Sandler rates it "overweight" with an $875 target, while Guggenheim and JPMorgan raised their targets to $975 and $950 respectively, maintaining buy ratings. Regeneron's average analyst rating is "Moderate Buy" with a target near $812.
MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

9 April 2026
MARA Holdings shares rose 1.7% to $9.67 Thursday despite Cantor Fitzgerald cutting its price target to $10. The company recently sold 15,133 bitcoin for $1.1 billion and agreed to repurchase $1 billion in convertible notes at a discount. MARA is expanding into AI and cloud infrastructure, but fourth-quarter revenue fell 6% and it posted a $1.7 billion net loss.
Bank of America (BAC) Stock Soars on Earnings Beat – Can It Keep Climbing?
Previous Story

Bank of America (BAC) Stock Today — November 7, 2025: Price, AI Rollout Across Workforce, UK Leadership Shuffle, and a Bond-Market Warning From BofA’s Strategist

Meta’s Q3 Showdown: Can AI Spend and Ad Growth Drive Another Rally?
Next Story

Meta (META) Stock Today, November 7, 2025: Shares Slip as $600B U.S. AI Buildout Meets Ad‑Fraud Furor

Go toTop